BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 25603171)

  • 1. Conformational nanobodies reveal tethered epidermal growth factor receptor involved in EGFR/ErbB2 predimers.
    Nevoltris D; Lombard B; Dupuis E; Mathis G; Chames P; Baty D
    ACS Nano; 2015 Feb; 9(2):1388-99. PubMed ID: 25603171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential and synergistic effects of epidermal growth factor receptor antibodies on unliganded ErbB dimers and oligomers.
    Kozer N; Kelly MP; Orchard S; Burgess AW; Scott AM; Clayton AH
    Biochemistry; 2011 May; 50(18):3581-90. PubMed ID: 21495621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand binding induces a conformational change in epidermal growth factor receptor dimers.
    Walker F; Rothacker J; Henderson C; Nice EC; Catimel B; Zhang HH; Scott AM; Bailey MF; Orchard SG; Adams TE; Liu Z; Garrett TP; Clayton AH; Burgess AW
    Growth Factors; 2012 Dec; 30(6):394-409. PubMed ID: 23163584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
    Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F
    Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR family: structure physiology signalling and therapeutic targets.
    Burgess AW
    Growth Factors; 2008 Oct; 26(5):263-74. PubMed ID: 18800267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells.
    Tao RH; Maruyama IN
    J Cell Sci; 2008 Oct; 121(Pt 19):3207-17. PubMed ID: 18782861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.
    Li Z; Mei Y; Liu X; Zhou M
    Cell Signal; 2007 Mar; 19(3):466-71. PubMed ID: 16978839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR kinase possesses a broad specificity for ErbB phosphorylation sites, and ligand increases catalytic-centre activity without affecting substrate binding affinity.
    Fan YX; Wong L; Johnson GR
    Biochem J; 2005 Dec; 392(Pt 3):417-23. PubMed ID: 16122376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling.
    Yu X; Sharma KD; Takahashi T; Iwamoto R; Mekada E
    Mol Biol Cell; 2002 Jul; 13(7):2547-57. PubMed ID: 12134089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active and inactive conformations of the epidermal growth factor receptor.
    Ferguson KM
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):742-5. PubMed ID: 15494003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative experimental/theoretical studies on the EGFR dimerization under the effect of EGF/EGF analogues binding: Highlighting the importance of EGF/EGFR interactions at site III interface.
    Mehrabi M; Mahdiuni H; Rasouli H; Mansouri K; Shahlaei M; Khodarahmi R
    Int J Biol Macromol; 2018 Aug; 115():401-417. PubMed ID: 29665393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of N-glycosylation in EGFR ectodomain ligand binding.
    Azimzadeh Irani M; Kannan S; Verma C
    Proteins; 2017 Aug; 85(8):1529-1549. PubMed ID: 28486782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of the effect of ErbB2 on epidermal growth factor receptor binding and dimerization.
    Li Y; Macdonald-Obermann J; Westfall C; Piwnica-Worms D; Pike LJ
    J Biol Chem; 2012 Sep; 287(37):31116-25. PubMed ID: 22822073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for extended YFP-EGFR dimers in the absence of ligand on the surface of living cells.
    Kozer N; Henderson C; Jackson JT; Nice EC; Burgess AW; Clayton AH
    Phys Biol; 2011 Dec; 8(6):066002. PubMed ID: 21946082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bispecific transmembrane antibody simultaneously targeting intra- and extracellular epitopes of the epidermal growth factor receptor inhibits receptor activation and tumor cell growth.
    Müller N; Hartmann C; Genssler S; Koch J; Kinner A; Grez M; Wels WS
    Int J Cancer; 2014 Jun; 134(11):2547-59. PubMed ID: 24243620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor (EGFR) signaling in cancer.
    Normanno N; De Luca A; Bianco C; Strizzi L; Mancino M; Maiello MR; Carotenuto A; De Feo G; Caponigro F; Salomon DS
    Gene; 2006 Jan; 366(1):2-16. PubMed ID: 16377102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
    Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH
    EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor mutant with wild-type affinity for both ErbB1 and ErbB3.
    Wingens M; Jacobs-Oomen S; van der Woning SP; Stortelers C; van Zoelen EJ
    Biochemistry; 2006 Apr; 45(14):4703-10. PubMed ID: 16584205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ErbB/HER receptor protein-tyrosine kinases and cancer.
    Roskoski R
    Biochem Biophys Res Commun; 2004 Jun; 319(1):1-11. PubMed ID: 15158434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.